Most brokers are still taking a well-earned break over the holiday period, so broker notes are few and far between right now.
In light of this, I thought I would take a look at a few that have been released over the last few weeks that remain very relevant today.
Three buy ratings you might want to pay attention to are listed below:
Appen Ltd (ASX: APX)
According to a note out of Wilsons, its analysts have retained their overweight rating but cut the price target on this artificial intelligence services company's shares to $32.11. The broker made the move after Appen downgraded its earnings guidance last month due to COVID-19 impacting demand from some of its larger customers. Wilsons believes the impact will be short term and expects Appen to bounce back once the pandemic passes. The Appen share price is trading at $23.93 on Thursday.
Healius Ltd (ASX: HLS)
Analysts at Goldman Sachs have retained their buy rating and lifted the price target on this healthcare company's shares to $4.40. According to the note, the broker has been pleased with its performance in FY 2021 and believes Healius is one of only a handful of value options on the Australian share market. So much so, it feels the company should be considered a core holding in 2021. Goldman expects consensus upgrades and multiple re-ratings to drive further stock performance through the mid-term. The Healius share price is changing hands for $3.79 today.
Kogan.com Ltd (ASX: KGN)
A note out of Canaccord Genuity reveals that its analysts have retained their buy rating and lifted the price target on this ecommerce company's shares to $25.00. It was pleased with the company's acquisition of New Zealand based online retailer Mighty Ape for $122 million. Canaccord Genuity believes there are a number of strategic rationales for the acquisition. This includes the potential for sizeable revenue and cost synergies. The broker has upgraded its earnings forecasts to reflect this. The Kogan share price is fetching $19.25 this afternoon.
